[Epstein-Barr virus (
Epstein-Barr Virus Infections
/ genetics
Gammaherpesvirinae
/ genetics
Gene Expression Regulation, Viral
/ drug effects
Genome, Viral
/ drug effects
Herpesvirus 4, Human
/ genetics
Host-Pathogen Interactions
/ genetics
Humans
Lymphocryptovirus
/ genetics
Virus Activation
/ drug effects
Virus Replication
/ drug effects
Journal
Voprosy virusologii
ISSN: 2411-2097
Titre abrégé: Vopr Virusol
Pays: Russia (Federation)
ID NLM: 0417337
Informations de publication
Date de publication:
16 Sep 2020
16 Sep 2020
Historique:
received:
16
09
2020
accepted:
16
09
2020
entrez:
3
2
2021
pubmed:
4
2
2021
medline:
26
10
2021
Statut:
epublish
Résumé
The Epstein-Barr virus (EBV), one of the most common in the human population, is capable of lifelong persistence in resting memory B-cells, in T-cells in case of type 2 EBV, and in some undifferentiated epithelial cells. In most people, EBV persistence is not accompanied by significant symptoms, but frequent virus activations are associated with the increased risks of severe diseases, such as chronic active Epstein-Barr virus infection, hemophagocytic lymphohistiocytosis, multiple sclerosis, systemic lupus erythematosus, gastric and nasopharyngeal carcinomas, and a variety of T- and B-cell lymphomas. Therefore, the molecular viral and host cell processes during asymptomatic or low-symptom EBV persistence are of great interest. This review describes the behavior of the viral DNA in an infected cell and the forms of its existence (linear, circular episome, chromosomally integrated forms), as well as methods of EBV genome copying. Two closely related cycles of viral reproduction are considered. Lytic activation is unfavorable for the survival of a particular viral genome in the cell, and may be a result of differentiation of a latently infected cell, or the arrival of stress signals due to adverse extracellular conditions. The EBV has a large number of adaptive mechanisms for limiting lytic reactivation and reducing hostility of host immune cells. Understanding the molecular aspects of EBV persistence will help in the future develop more effective targeted drugs for the treatment of both viral infection and associated diseases.
Identifiants
pubmed: 33533222
doi: 10.36233/0507-4088-2020-65-4-191-202
doi:
Types de publication
Journal Article
Langues
rus
Sous-ensembles de citation
IM